‘Makers of the leading coronavirus vaccine candidates disclosed detailed information about their pivotal late-stage clinical trials and how they plan to gauge their shots' safety and effectiveness. The moves by first Moderna Inc, and then later from Pfizer Inc and its partner BioNTech SE, follow increasing worry that the effort to develop a Covid-19 vaccine is becoming politicised, and that an inoculation could be rushed to market before it is proven safe and effective. AstraZeneca said in an e-mail it would share its plans as well, though it hadn't as of Thursday (Sept 17) evening in the US.’
Read here (Straits Times, Sept 18, 2020)
